These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29074146)

  • 21. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
    Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
    BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior.
    Gavaza P; Fleming M; Barner JC
    Res Social Adm Pharm; 2014; 10(2):448-58. PubMed ID: 23953982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community pharmacists' naloxone counseling: A theory-informed qualitative study.
    Rawal S; Osae SP; Tackett RL; MacKinnon NJ; Soiro FD; Young HN
    J Am Pharm Assoc (2003); 2023; 63(6):1743-1752.e2. PubMed ID: 37633453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
    Winslade N; Tamblyn R
    BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring pharmacists' perceptions regarding influenza and streptococcal testing within a chain pharmacy.
    Dulaney K; Hohmeier K; Fisher C; Cardosi L; Wasson M
    J Am Pharm Assoc (2003); 2018; 58(4):438-441.e1. PubMed ID: 29691199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From personal crisis care to convenience shopping: an interpretive description of the experiences of people with mental illness and addictions in community pharmacies.
    Murphy AL; Martin-Misener R; Kutcher SP; O'Reilly CL; Chen TF; Gardner DM
    BMC Health Serv Res; 2016 Oct; 16(1):569. PubMed ID: 27729051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of intentions to monitor antihypertensive medication adherence in Irish community pharmacy: a factorial survey.
    Dillon P; McDowell R; Smith SM; Gallagher P; Cousins G
    BMC Fam Pract; 2019 Sep; 20(1):131. PubMed ID: 31519171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication adherence beliefs of U.S community pharmacists.
    Witry MJ
    Res Social Adm Pharm; 2018 May; 14(5):471-478. PubMed ID: 28655492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physician beliefs and attitudes toward collaboration with community pharmacists.
    Kucukarslan S; Lai S; Dong Y; Al-Bassam N; Kim K
    Res Social Adm Pharm; 2011 Sep; 7(3):224-32. PubMed ID: 21272527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosocial factors associated with pharmacists' antidepressant drug treatment monitoring.
    Lauzier S; Guillaumie L; Humphries B; Grégoire JP; Moisan J; Villeneuve D
    J Am Pharm Assoc (2003); 2020; 60(4):548-558. PubMed ID: 32173335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists' perspectives.
    Kennelty KA; Chewning B; Wise M; Kind A; Roberts T; Kreling D
    Res Social Adm Pharm; 2015; 11(4):517-30. PubMed ID: 25586885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and motivational factors for engaging in novel opioid and medication disposal-related services in community pharmacies.
    Barnett MJ; Clubbs B; Woodyard A; Wasem V; Prinze J; Tirupasur A; Hosseini S; Kim M; Gallardo F; Polich N; Desselle S
    Res Social Adm Pharm; 2024 Aug; 20(8):713-722. PubMed ID: 38719767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Adherence Education and Monitoring on Community Pharmacy Performance Scores and Patient Satisfaction.
    Sprouse C; Grant M; Remines J; Nadpara P; Goode JV
    Innov Pharm; 2020; 11(3):. PubMed ID: 34007625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacists' perspective of medication adherence support in Ethiopian hospital settings: a qualitative study.
    Tegegn HG; Wark S; Tursan d'Espaignet E; Spark MJ
    Int J Pharm Pract; 2023 Dec; 31(6):617-624. PubMed ID: 37721550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
    Erickson SC; Leslie RS; Patel BV
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1129-36. PubMed ID: 25351974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the Human Factors Framework to understand the origins of medication safety problems in community pharmacy: A qualitative study.
    Al Juffali L; Al-Aqeel S; Knapp P; Mearns K; Family H; Watson M
    Res Social Adm Pharm; 2019 May; 15(5):558-567. PubMed ID: 30031695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative study to conceptualise a model of interprofessional collaboration between pharmacists and general practitioners to support patients' adherence to medication.
    Rathbone AP; Mansoor SM; Krass I; Hamrosi K; Aslani P
    BMJ Open; 2016 Mar; 6(3):e010488. PubMed ID: 26983948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.